Compass Pathways President Steps Down To An Advisory Role
Compass Pathways (Nasdaq: CMPS) announced this morning major changes to its executive team. One of its co-founders, President and Chief Business
Read more
Compass Pathways
Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin
Compass Pathways (NASDAQ: CMPS) this morning issued a brief release, indicating it has been granted a fifth patent in the
Read more
Compass: Canaccord Reiterates $80 Price Target After Study Data
Earlier this month, Compass Pathways (Nasdaq: CMPS) announced positive topline results and its key findings in its Phase 2b clinical
Read more
Compass Pathways Sees “Reduction In Depressive Symptom” In Phase IIb Psilocybin Clinical Trial
Compass Pathways (Nasdaq: CMPS) announced today that its phase IIb clinical trial of COMP360 psilocybin therapy has achieved its primary endpoint.
Read more
Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy
Compass Pathways (Nasdaq: CMPS) this morning announced that it will be launching the phase II clinical trial for its synthetic psilocybin
Read more
Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial
Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the latest status of its ongoing
Read more
Psychedelics: The Eight Capital Primer
Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read more
David Nutt: Amanita Muscaria Due For More Research – The Daily Dive
Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the
Read more
Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens
Today on the Daily Dive, Jeff Stevens returns to the show to sit down with host Cassandra Leah to discuss
Read more
Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health
In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably been that of the growing
Read more